Invited Speaker: Captain Robyn Bent (virtual) (1:15pm-1:45pm) Patient Focused Drug Development and the Rare Diseases Cures Accelerator Oral Presentations (1:45pm-2:35pm)
Current and future therapies for HHT: Mechanistic and clinical considerations
AVM formation and progression: Mechanistic and clinical considerations
Speakers: Dr. Miles Conrad and Dr. Els de Gussem
Overview of eight priority research areas identified by the patient, clinician and science communities.
Highlight of 7 posters for the afternoon
Preclinical Models of HHT Disease: Mechanisms, Therapies and Controversies
A warm welcome from the Organizing Committee Co-Chair and an encouraging patient story.